How to approach neutropenia

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• Neutropenia is a reduced absolute neutrophil count, with acute forms being common and often self-resolving.
• Chronic neutropenia, lasting over three months, results from decreased production, increased destruction, or splenic sequestration.
• Neutropenia can be secondary to external factors, an acquired myeloid progenitor disorder, or a rare intrinsic defect.

Purpose of the Study:

• To define neutropenia and its classifications.
• To highlight the significance of neutropenia arising from hematologic disorders.
• To discuss the implications of severe neutropenia and genetic defects.

Main Methods:

• Literature review and synthesis of existing knowledge on neutropenia.
• Classification of neutropenia based on duration, cause, and origin.
• Discussion of diagnostic considerations and associated risks.

Main Results:

• Acute neutropenia is frequent and usually benign, while chronic neutropenia poses greater risks.
• Severe neutropenia (ANC < 500/μL) significantly elevates susceptibility to bacterial and fungal infections.
• Genetic defects in severe congenital neutropenia impact neutrophil precursor differentiation, adhesion, and apoptosis.

Conclusions:

• Neutropenia requires thorough investigation, especially when linked to hematologic disorders.
• Understanding genetic defects provides insights into neutrophil biology and associated risks like myelodysplasia and acute myeloid leukemia.
• Severe neutropenia necessitates prompt management to mitigate infectious complications.